Related references
Note: Only part of the references are listed.Formoterol, a Long-Acting β2 Adrenergic Agonist, Improves Cognitive Function and Promotes Dendritic Complexity in a Mouse Model of Down Syndrome
Van Dang et al.
BIOLOGICAL PSYCHIATRY (2014)
Sex Differences in the Cholinergic Basal Forebrain in the Ts65Dn Mouse Model of Down Syndrome and Alzheimer's Disease
Christy M. Kelley et al.
BRAIN PATHOLOGY (2014)
Maternal choline supplementation differentially alters the basal forebrain cholinergic system of young-adult Ts65Dn and disomic mice
Christy M. Kelley et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2014)
Glutamatergic Transmission Aberration: A Major Cause of Behavioral Deficits in a Murine Model of Down's Syndrome
Gurjinder Kaur et al.
JOURNAL OF NEUROSCIENCE (2014)
Synaptic gene dysregulation within hippocampal CA1 pyramidal neurons in mild cognitive impairment
Scott E. Counts et al.
NEUROPHARMACOLOGY (2014)
Effects of Memantine on Clinical Ratings, Fluorodeoxyglucose Positron Emission Tomography Measurements, and Cerebrospinal Fluid Assays in Patients With Moderate to Severe Alzheimer Dementia A 24-Week, Randomized, Clinical Trial
Tao Wang et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2013)
CRISPR RNA-guided activation of endogenous human genes
Morgan L. Maeder et al.
NATURE METHODS (2013)
Maternal choline supplementation improves spatial learning and adult hippocampal neurogenesis in the Ts65Dn mouse model of Down syndrome
Ramon Velazquez et al.
NEUROBIOLOGY OF DISEASE (2013)
Aβ induces astrocytic glutamate release, extrasynaptic NMDA receptor activation, and synaptic loss
Maria Talantova et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Alzheimer's disease, β-amyloid, glutamate, NMDA receptors and memantine - searching for the connections
Wojciech Danysz et al.
BRITISH JOURNAL OF PHARMACOLOGY (2012)
Neuroprotective Effects of Reactive Oxygen Species Mediated by BDNF-Independent Activation of TrkB
Yang Zhong Huang et al.
JOURNAL OF NEUROSCIENCE (2012)
Memantine for dementia in adults older than 40 years with Down's syndrome (MEADOWS): a randomised, double-blind, placebo-controlled trial
Marisa Hanney et al.
LANCET (2012)
Microarray analysis of CA1 pyramidal neurons in a mouse model of tauopathy reveals progressive synaptic dysfunction
Melissa J. Alldred et al.
NEUROBIOLOGY OF DISEASE (2012)
Gene expression levels assessed by CA1 pyramidal neuron and regional hippocampal dissections in Alzheimer's disease
Stephen D. Ginsberg et al.
NEUROBIOLOGY OF DISEASE (2012)
Analyzing Gene Expression from Whole Tissue vs. Different Cell Types Reveals the Central Role of Neurons in Predicting Severity of Alzheimer's Disease
Shiri Stempler et al.
PLOS ONE (2012)
Antagonism of NMDA receptors as a potential treatment for Down syndrome: a pilot randomized controlled trial
R. Boada et al.
TRANSLATIONAL PSYCHIATRY (2012)
Effects of long-term memantine on memory and neuropathology in Ts65Dn mice, a model for Down syndrome
Jason Lockrow et al.
BEHAVIOURAL BRAIN RESEARCH (2011)
The use of mouse models to understand and improve cognitive deficits in Down syndrome
Ishita Das et al.
DISEASE MODELS & MECHANISMS (2011)
Gender differences in neurotrophin and glutamate receptor expression in cholinergic nucleus basalis neurons during the progression of Alzheimer's disease
Scott E. Counts et al.
JOURNAL OF CHEMICAL NEUROANATOMY (2011)
Transcript catalogs of human chromosome 21 and orthologous chimpanzee and mouse regions
Xiaolu Sturgeon et al.
MAMMALIAN GENOME (2011)
Synaptic dysfunction in hippocampus of transgenic mouse models of Alzheimer's disease: A multi-electrode array study
Seon-Ah Chong et al.
NEUROBIOLOGY OF DISEASE (2011)
Therapeutic significance of NR2B-containing NMDA receptors and mGluR5 metabotropic glutamate receptors in mediating the synaptotoxic effects of β-amyloid oligomers on long-term potentiation (LTP) in murine hippocampal slices
Gerhard Rammes et al.
NEUROPHARMACOLOGY (2011)
Perinatal Choline Supplementation Improves Cognitive Functioning and Emotion Regulation in the Ts65Dn Mouse Model of Down Syndrome
Jisook Moon et al.
BEHAVIORAL NEUROSCIENCE (2010)
Microarray Analysis of Hippocampal CA1 Neurons Implicates Early Endosomal Dysfunction During Alzheimer's Disease Progression
Stephen D. Ginsberg et al.
BIOLOGICAL PSYCHIATRY (2010)
Updated National Birth Prevalence Estimates for Selected Birth Defects in the United States, 2004-2006
Samantha E. Parker et al.
BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY (2010)
Preventing Ca2+-mediated nitrosative stress in neurodegenerative diseases: Possible pharmacological strategies
Tomohiro Nakamura et al.
CELL CALCIUM (2010)
Learning discloses abnormal structural and functional plasticity at hippocampal synapses in the APP23 mouse model of Alzheimer's disease
Silvia Middei et al.
LEARNING & MEMORY (2010)
Alzheimer's-related endosome dysfunction in Down syndrome is Aβ-independent but requires APP and is reversed by BACE-1 inhibition
Ying Jiang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Characterizations and validations of novel antibodies toward translational research
Reginald Williams et al.
PROTEOMICS CLINICAL APPLICATIONS (2010)
Cholinergic degeneration and memory loss delayed by vitamin E in a Down syndrome mouse model
Jason Lockrow et al.
EXPERIMENTAL NEUROLOGY (2009)
The Down Syndrome Critical Region Is Sufficient in the Mouse Model to Confer Behavioral, Neurophysiological, and Synaptic Phenotypes Characteristic of Down Syndrome
Nadia P. Belichenko et al.
JOURNAL OF NEUROSCIENCE (2009)
Terminal continuation (TC) RNA amplification without second strand synthesis
Melissa J. Alldred et al.
JOURNAL OF NEUROSCIENCE METHODS (2009)
In vivo MRI identifies cholinergic circuitry deficits in a Down syndrome model
Yuanxin Chen et al.
NEUROBIOLOGY OF AGING (2009)
Genetic association of neurotrophic tyrosine kinase receptor type 2 (NTRK2) with Alzheimer's disease
Zuomin Chen et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS (2008)
The Biology of Neurotrophins, Signalling Pathways, and Functional Peptide Mimetics of Neurotrophins and their Receptors
Stephen D. Skaper
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS (2008)
Terminal Continuation (TC) RNA Amplification Enables Expression Profiling Using Minute RNA Input Obtained from Mouse Brain
Melissa J. Alldred et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2008)
Abnormal expression of synaptic proteins and neurotrophin-3 in the down syndrome mouse model Ts65Dn
G. Pollonini et al.
NEUROSCIENCE (2008)
Acute injections of the NMDA receptor antagonist memantine rescue performance deficits of the Ts65Dn mouse model of Down syndrome on a fear conditioning test
Alberto C. S. Costa et al.
NEUROPSYCHOPHARMACOLOGY (2008)
Correlation and large-scale simultaneous significance testing
Bradley Efron
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION (2007)
Nerve growth factor gene therapy in Alzheimer disease
Mark H. Tuszynski
ALZHEIMER DISEASE & ASSOCIATED DISORDERS (2007)
Cholinotrophic molecular substrates of mild cognitive impairment in the elderly
Elliott J. Mufson et al.
CURRENT ALZHEIMER RESEARCH (2007)
Hippocampal hypocellularity in the Ts65Dn mouse originates early in development
Hernan A. Lorenzi et al.
BRAIN RESEARCH (2006)
Increased App expression in a mouse model of Down's syndrome disrupts NGF transport and causes cholinergic neuron degeneration
Ahmad Salehi et al.
NEURON (2006)
Down regulation of trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer's disease
SD Ginsberg et al.
JOURNAL OF NEUROCHEMISTRY (2006)
A 24-week open-label extension study of memantine in moderate to severe Alzheimer disease
B Reisberg et al.
ARCHIVES OF NEUROLOGY (2006)
RNA amplification strategies for small sample populations
SD Ginsberg
METHODS (2005)
Signaling endosome hypothesis: A cellular mechanism for long distance communication
CL Howe et al.
JOURNAL OF NEUROBIOLOGY (2004)
Synaptic structural abnormalities in the Ts65Dn mouse model of Down syndrome
PV Belichenko et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2004)
Transactivation of Trk neurotrophin receptors by G-protein-coupled receptor ligands occurs on intracellular membranes
R Rajagopal et al.
JOURNAL OF NEUROSCIENCE (2004)
Amplification of RNA transcripts using terminal continuation
SL Che et al.
LABORATORY INVESTIGATION (2004)
Differential preservation of AMPA receptor subunits in the hippocampi of Alzheimer's disease patients according to Braak stage
TL Carter et al.
EXPERIMENTAL NEUROLOGY (2004)
Mouse models of Down syndrome: how useful can they be? Comparison of the gene content of human chromosome 21 with orthologous mouse genomic regions
K Gardiner et al.
GENE (2003)
Global disruption of the cerebellar transcriptome in a Down syndrome mouse model
NG Saran et al.
HUMAN MOLECULAR GENETICS (2003)
Memantine in moderate-to-severe Alzheimer's disease
B Reisberg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Regional alterations in amyloid precursor protein and nerve growth factor across age in a mouse model of Down's syndrome
CL Hunter et al.
NEUROSCIENCE RESEARCH (2003)
Estrogen alters amyloid precursor protein as well as dendritic and cholinergic markers in a mouse model of Down syndrome
AC Granholm et al.
HIPPOCAMPUS (2003)
Growth-factor gene therapy for neurodegenerative disorders
MH Tuszynski
LANCET NEUROLOGY (2002)
Failed retrograde transport of NGF in a mouse model of Down's syndrome: Reversal of cholinergic neurodegenerative phenotypes following NGF infusion
JD Cooper et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Ts65Dn - localization of the translocation breakpoint and trisomic gene content in a mouse model for Down syndrome
EC Akeson et al.
CYTOGENETICS AND CELL GENETICS (2001)
Endocytic pathway abnormalities precede amyloid β deposition in sporadic Alzheimer's disease and Down syndrome -: Differential effects of APOE genotype and presenilin mutations
AM Cataldo et al.
AMERICAN JOURNAL OF PATHOLOGY (2000)
Synaptic deficit in the temporal cortex of partial trisomy 16 (Ts65Dn) mice
MA Kurt et al.
BRAIN RESEARCH (2000)
Loss of cholinergic phenotype in basal forebrain coincides with cognitive decline in a mouse model of Down's syndrome
ACE Granholm et al.
EXPERIMENTAL NEUROLOGY (2000)
Share Paper
